Healthcare Equipment and Supplies
Company Overview of Entellus Medical, Inc.
Entellus Medical, Inc., a medical technology company, designs, develops, and commercializes products for the minimally invasive treatment of patients in the physician office setting or operating room suffering from chronic sinusitis. It offers XprESS Multi-Sinus Dilation family of products consisting of XprESS device and XprESS LoProfile device, which open an obstructed or narrowed drainage pathway of a sinus cavity by means of trans-nasal balloon sinus dilation; and FinESS sinus dilation system, a solution for treatment of the maxillary sinus drainage pathway. The company also provides PathAssist tools, such as LED Light Fiber, a single-use tool that provides high intensity red transillumin...
3600 Holly Lane North
Plymouth, MN 55447
Founded in 2006
Key Executives for Entellus Medical, Inc.
Chairman of the Board and Chief Executive Officer
President and Chief Operating Officer
Co-Founder and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2014.
Entellus Medical, Inc. Key Developments
Entellus Medical Mulls Acquisitions
Dec 23 14
Entellus Medical, Inc. is looking for acquisitions. Entellus Medical, Inc. has filed an initial public offering in the amount of $69 million and intends to use a portion of the net proceeds to co-develop, acquire or invest in products, technologies or businesses that are complementary to their business.
Oxford Finance Closes $25 Million Senior Credit Facility with Entellus Medical
Jan 8 14
Oxford Finance LLC announced that it entered into a term loan agreement with Entellus Medical, Inc. that expanded the original $17 million loan facility to $25 million. Entellus is using proceeds of the loan to support business operations and the ongoing marketing efforts for its minimally invasive treatments for chronic sinusitis.
Entellus Medical and CogENT Therapeutics Announce Distribution Agreement
Sep 30 13
Entellus Medical and CogENT Therapeutics announced they have reached an exclusive distribution agreement. Entellus will distribute CogENT's XeroGel(R) nasal/epistaxis pack to ENT physicians. The agreement makes Entellus Medical the sole distributor of XeroGel in the United States. XeroGel nasal/epistaxis pack is a dissolvable co-polymer of chitosan and polyethylene glycol. Upon placement, the pack absorbs fluids in the surgical field and conforms to the treatment site in order to minimize post-surgical bleeding, prevent adhesions between mucosal surfaces, and aid in the natural healing process. In addition, XeroGel can be used for the treatment of epistaxis.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries